PB2315: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)
Yue Teng,
Weiyan Tang,
Zhiya Wu,
Yuxin Du,
Jianqiu Wu
Affiliations
Yue Teng
1 Jiangsu Cancer Hospital &Jiangsu Institute of Cancer Research &The Affiliated Cancer Hospital of Nanjing Medical University, Medical Oncology, Nanjing, China
Weiyan Tang
2 Jiangsu Cancer Hospital &Jiangsu Institute of Cancer Research &The Affiliated Cancer Hospital of Nanjing Medical University, Medical Oncology, Nanjing, China
Zhiya Wu
3 Jiangsu Cancer Hospital &Jiangsu Institute of Cancer Research &The Affiliated Cancer Hospital of Nanjing Medical University, Medical Oncology, Nanjing, China
Yuxin Du
2 Jiangsu Cancer Hospital &Jiangsu Institute of Cancer Research &The Affiliated Cancer Hospital of Nanjing Medical University, Medical Oncology, Nanjing, China
Jianqiu Wu
2 Jiangsu Cancer Hospital &Jiangsu Institute of Cancer Research &The Affiliated Cancer Hospital of Nanjing Medical University, Medical Oncology, Nanjing, China
